Drug intelligence / Profile preview

Hemidesmus indicus

Development stage: Unknown
Administration: Oral, Topical

Overview

Hemidesmus indicus, commonly known as Indian Sarsaparilla or Sariva, is a perennial plant with significant traditional medicinal value. It is part of the Apocynaceae family and is used in Ayurveda for various health benefits, including anti-inflammatory, anti-diabetic, hepatoprotective, anticancer, and neuroprotective activities. The plant contains phytochemicals like flavonoids, tannins, and terpenoids, contributing to its therapeutic potential.

Other names: Indian SarsaparillaSarivaAnantamul

Targets

Sucrase-IsomaltaseIGF-1R (Insulin-like growth factor 1 receptor)Human immunodeficiency virus type 1 reverse transcriptaseAR (Adrenergic receptors)MEK1 (Dual specificity mitogen-activated protein kinase kinase 1)

Beyond the preview

Go deeper on Hemidesmus indicus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemidesmus indicus.

Explore the full profile